COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
COMMUNIQUE RELATIF A LA MISE A DISPOSITION DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE TALAN HOLDING DANS LE CADRE DE L'OFFRE PUBLIQUE D'ACHAT VISANT MICROPOLE
Annonce de l'offre publique d'achat de Micropole par Talan Holding SAS, présentée par Oddo BHF pour 3,12 euros par action ordinaire -
COMMUNIQUÉ DE PRESSE
Park Lawn Continues Growth Strategy by Expanding Presence in North Carolina and Central Texas and Announces Leadership Changes
Park Lawn Corporation expands its presence in North Carolina and central Texas through strategic acquisitions of Carolina-Whitley and WHB assets. Leadership changes announced to support organizational growth -
COMMUNIQUÉ DE PRESSE
Upstream Works Announces Omni AI Hub and Upstream Works AI Availability for On-Premise and Cloud Contact Centers
Upstream Works announces Omni AI Hub and Upstream Works AI for contact centers, offering AI orchestration capabilities for enhanced efficiency and customer experiences -
-
COMMUNIQUÉ DE PRESSE
From Hundreds of Submissions, Epique Realty Named Semi-Finalist in 2024 Exhibit Brokerage Brand Awards
Epique Realty selected as semi-finalist in Exhibit Brokerage Brand Awards 2024, positioning themselves as a rising force in the industry. Winners to be announced at T3 Tech Summit -
-
COMMUNIQUÉ DE PRESSE
myphysician360 Appoints Dr. Akash Parekh as Chief Medical Officer
Dr. Akash Parekh appointed as Chief Medical Officer at myphysician360, a leader in virtual healthcare for rural areas. His expertise in health tech and underserved patient care will drive innovation in expanding services -
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Appoints Industry Veteran to Head Sales for Company’s Commercialized Oncology and HIV Products Including October 2024 Launch of Gelclair for Cancer Supportive Care
Jaguar Health, Inc. appoints Susan Krizancic as National Sales Director for Napo Pharmaceuticals, preparing for FDA-approved Gelclair® oral mucositis product launch in October 2024
